EDGAR Filing Documents for 0001193125-18-122697

Form 8-K - Current report:

SEC Accession No. 0001193125-18-122697

Filing Date

2018-04-19

Accepted

2018-04-19 16:31:57

Documents

Period of Report

2018-04-16

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d575484d8k.htm	8-K	29254
2	EX-1.1	d575484dex11.htm	EX-1.1	226954
3	EX-1.2	d575484dex12.htm	EX-1.2	231077
4	EX-4.1	d575484dex41.htm	EX-4.1	281429
5	EX-4.2	d575484dex42.htm	EX-4.2	352873
6	EX-5.1	d575484dex51.htm	EX-5.1	16222
7	EX-99.1	d575484dex991.htm	EX-99.1	10229
8	EX-99.2	d575484dex992.htm	EX-99.2	9616
9	GRAPHIC	g575484dsp45.jpg	GRAPHIC	2838
10	GRAPHIC	g575484dsp46.jpg	GRAPHIC	3577
11	GRAPHIC	g575484dsp47.jpg	GRAPHIC	3833
12	GRAPHIC	g575484dsp48.jpg	GRAPHIC	3902
13	GRAPHIC	g575484dsp49.jpg	GRAPHIC	3330
14	GRAPHIC	g575484dsp50.jpg	GRAPHIC	4688
15	GRAPHIC	g575484g15z37.jpg	GRAPHIC	3601
16	GRAPHIC	g575484snap0001.jpg	GRAPHIC	3902
17	GRAPHIC	g575484willkie.jpg	GRAPHIC	4155
	Complete submission text file	0001193125-18-122697.txt		1206856

Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301

Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000

Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)